Albany International Schedules Earnings Release Date
Get Alerts AIN Hot Sheet
Join SI Premium – FREE
ROCHESTER, N.H.--(BUSINESS WIRE)-- Albany International Corp. (NYSE: AIN) will release 2025 first-quarter results Wednesday, April 30, 2025 after the market closes. The Company will host a webcast to discuss results at 9:00 a.m. Eastern Time on Thursday, May 1, 2025. Interested parties are encouraged to listen to the live webcast via the Company’s Investor Relations website at investors.albint.com.
Interested parties may access dial-in information for the call by registering via web link here.
An archive of the webcast will be available for replay on the website at approximately noon Eastern Time on Thursday, May 1, 2025.
About Albany International Corp.
Albany International is a leading developer and manufacturer of engineered components, using advanced materials processing and automation capabilities, with two core businesses.
- Machine Clothing is the world’s leading producer of custom-designed, consumable belts essential for the manufacture of paper, paperboard, tissue and towel, pulp, non-wovens and a variety of other industrial applications.
- Albany Engineered Composites is a growing designer and manufacturer of advanced materials-based engineered components for demanding aerospace applications, supporting both commercial and military platforms.
Albany International is headquartered in Rochester, New Hampshire, operates 30 facilities in 13 countries, employs approximately 5,400 people worldwide, and is listed on the New York Stock Exchange (Symbol: AIN). Additional information about the Company and its products and services can be found at www.albint.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250417025516/en/
Investor / Media Contact:
JC Chetnani
VP-Investor Relations and Treasurer
[email protected]
Source: Albany International Corp.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
- RiboX Therapeutics Announces FDA IND Clearance for RXIM002, the first Circular RNA-Based in vivo CAR Therapy for Autoimmune Cytopenias
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share